What is the public impact of scientific research? What are, and why are relevant, the accreditation requirements and validation of hypotheses and therapeutic procedures?
Michele De Luca is Professor of Regenerative medicine at the Department of Life Sciences and directs the "Stefano Ferrari" Regenerative Medicine Center at the University of Modena and Reggio Emilia. It has been dealing with epithelial stem cells for many years and is considered an international benchmark for cell therapy and gene therapy of many pathologies of coating epithelia. He is Co-President of the Luca Coscioni Association since 2013. In 2017 he was elected researcher of the year (Stem Cell Person of the Year award) for the exceptional results obtained in the field of stem cells and for his commitment in defense of scientific rigor applied to regenerative medicine, while in 2018 he received the "Black Pearl" award from Eurordis (Rare Disease Europe) and the "Innovation Award" of the ISCCR (The International Society of Stem Cell Research). He has written numerous articles in national and international journals, such as "Nature", "Stem Cells", "Regenerative Medicine", and contributed to international publications.